CPT code 84630 is a clinical laboratory service that quantifies zinc in blood, urine, or other specimens to detect zinc deficiency or excess. Zinc measurement is clinically relevant for assessing nutritional status, metabolic function, and disorders affecting insulin production and growth hormone pathways. Nationally, zinc testing supports diagnostic workflows in endocrinology, nutrition, pediatrics, and toxicology and informs treatment planning where trace mineral balance is relevant.

Key payers covered in this publication include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for zinc testing, typical sites of service, and the scope of services represented by the code. The report summarizes common billing modifiers and operational considerations for laboratories, and outlines benchmarking and reimbursement context where available. Where specific payer policies or coverage criteria differ, this publication highlights common themes across major commercial and federal payers.

This summary provides clinical and billing context for laboratory administrators, billing professionals, and policy analysts seeking concise information on CPT code 84630, including what the code represents, how it is used in clinical pathways, and which payers are most relevant for coverage and claims processing. Data not available in the input is noted where applicable.